Validation of AGA clinical care pathway and AASLD practice guidance for nonalcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetesVeeral Ajmera, Rohit Loomba, Kaleb Tesfai et al.|Hepatology|2023Cited by 30
A Prospective Study on the Prevalence of <scp>MASLD</scp> in Patients With Type 2 Diabetes and HyperferritinaemiaMaral Amangurbanova, Rohit Loomba, Nabil Noureddin et al.|Alimentary Pharmacology & Therapeutics|2024Cited by 22
Development and Validation of the Nonalcoholic Fatty Liver Disease Familial Risk Score to Detect Advanced Fibrosis: A Prospective, Multicenter StudyDaniel Q. Huang, Rohit Loomba, Noora Ahlholm et al.|Clinical Gastroenterology and Hepatology|2023Cited by 13
Effects of Food Insecurity on Hepatic Steatosis and Fibrosis in People With HIVAni Kardashian, Christie Hernandez, Audrey R. Lloyd et al.|Clinical Gastroenterology and Hepatology|2024Cited by 7
Validation and expansion of the American gastroenterological association clinical care pathway for non-alcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetesVeeral Ajmera, Rohit Loomba, Kaleb Tesfai et al.|Journal of Hepatology|2023Cited by 2